prediction

You have access
Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer
KENTARO SATO, REI SUZUKI, NAOKI KONNO, HIROKI IRIE, KO WATANABE, HIROMICHI IMAIZUMI, YUICHI WARAGAI, MITSURU SUGIMOTO, HIROYUKI ASAMA, HIROSHI SHIMIZU, REI OHIRA and HIROMASA OHIRA

Anticancer Research October 2025, 45 (10) 4509-4518; DOI: https://doi.org/10.21873/anticanres.17798
Open Access
Biomarkers Predicting Progression and Prognosis of Ductal Carcinoma In Situ (DCIS)
RHEA BHALA, LESLIE FAYE CANDO, PRISHA VERMA, TAIWO ADESOYE and ANJANA BHARDWAJ

Anticancer Research April 2025, 45 (4) 1305-1328; DOI: https://doi.org/10.21873/anticanres.17518
You have access
Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer
CAROLINE LENZ, LARA GESEMANN, YUSSOR AL-BALDAWI, MICHAEL PÜSKEN, AMELIE WINGELS, PETER MALLMANN, CONSTANZE AMIR-KARIBIAN, JANICE K. JESCHKE, JANA ADAMS, BERND MORGENSTERN and FABINSHY THANGARAJAH

Anticancer Research November 2024, 44 (11) 5081-5085; DOI: https://doi.org/10.21873/anticanres.17332
Open Access
Combination of Clinical Factors and Radiomics Can Predict Local Recurrence and Metastasis After Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer
YUKO ISOYAMA-SHIRAKAWA, TADAMASA YOSHITAKE, KENTA NINOMIYA, KAORI ASAI, KEIJI MATSUMOTO, YOSHIYUKI SHIOYAMA, TAKUMI KODAMA, KOUSEI ISHIGAMI and HIDETAKA ARIMURA

Anticancer Research November 2023, 43 (11) 5003-5013; DOI: https://doi.org/10.21873/anticanres.16699
You have access
Review of the Role of Radiomics in Tumour Risk Classification and Prognosis of Cancer
YEO LI WEN and MICHELLE LEECH

Anticancer Research July 2020, 40 (7) 3605-3618; DOI: https://doi.org/10.21873/anticanres.14350
You have access
Development of Normal Tissue Complication Probability Model for Trismus in Head and Neck Cancer Patients Treated With Radiotherapy: The Role of Dosimetric and Clinical Factors
MASAHIRO MORIMOTO, HENK P. BIJL, ARJEN VAN DER SCHAAF, CHENG-JIAN XU, ROEL J.H.M. STEENBAKKERS, OLGA CHOUVALOVA, YASUO YOSHIOKA, TERUKI TESHIMA and JOHANNES A. LANGENDIJK

Anticancer Research December 2019, 39 (12) 6787-6798; DOI: https://doi.org/10.21873/anticanres.13894
You have access
Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response
JULIA KOVACOVA, JAROSLAV JURACEK, ALEXANDR POPRACH, TOMAS BUCHLER, JINDRICH KOPECKY, ONDREJ FIALA, MAREK SVOBODA and ONDREJ SLABY

Anticancer Research May 2018, 38 (5) 2961-2965;
You have access
Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer
DIRK RADES, LIESA DZIGGEL, THEO VENINGA, AMIRA BAJROVIC and STEVEN E. SCHILD

Anticancer Research September 2016, 36 (9) 4817-4819;
You have access
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, ONDREJ TOPOLCAN, JAROSLAV RACEK, MARTIN SVATON, RADEK KUCERA, MAREK MINARIK, LUCIE BENESOVA, ZBYNEK BORTLICEK, RENATA CHLOUPKOVA, ALEXANDR POPRACH and TOMAS BUCHLER

Anticancer Research May 2016, 36 (5) 2459-2465;
You have access
Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma
IVAN TRÁVNÍČEK, JINDŘICH BRANŽOVSKÝ, KRISTÝNA KALUSOVÁ, ONDŘEJ HES, LUBOŠ HOLUBEC, KEVIN BAULETH PELE, TOMÁŠ ÜRGE and MILAN HORA

Anticancer Research October 2015, 35 (10) 5661-5666;

Main menu

User menu

Search

prediction

Pages